Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine-rich repeat and death domain-containing protein 1 (LRRD1) is a human protein encoded by the LRRD1 gene. The protein contains leucine-rich repeats (LRR), which are structural motifs involved in mediating protein-protein interactions, and a death domain (DD), which is commonly found in proteins involved in apoptosis or inflammation signaling. However, the specific molecular functions of LRRD1 remain poorly understood and it is currently considered a protein of uncertain function. No described enzymatic activity or direct receptor signaling role is attributed to LRRD1, and it is not recognized as a target for drug therapy or as a disease biomarker. Its roles—if any—are likely to be as a scaffold/adaptor protein facilitating complexes of other signaling molecules.
None known (no evidence of drugs targeting this protein; thus, no known mechanisms)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine-rich repeat and death domain-containing protein 1 (LRRD1).